130 related articles for article (PubMed ID: 1717024)
21. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
[TBL] [Abstract][Full Text] [Related]
22. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology.
Bedrossian CW
Diagn Cytopathol; 1998 Feb; 18(2):141-9. PubMed ID: 9484644
[No Abstract] [Full Text] [Related]
23. New diagnostic technique for rapid fluorescence immunocytochemical staining of adenocarcinoma and mesothelial cells using liquid-based cytology.
Morimoto A; Ito A; Hashimoto K; Nakano A; Nagasaka T; Yokoi T
Acta Cytol; 2014; 58(5):461-8. PubMed ID: 25358455
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of the immunocytochemical study of body fluids.
Li CY; Ziesmer SC; Wong YC; Yam LT
Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical staining on ThinPrep processed smears.
Leung SW; Bédard YC
Mod Pathol; 1996 Mar; 9(3):304-6. PubMed ID: 8685232
[TBL] [Abstract][Full Text] [Related]
26. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic cytology of serous effusions (author's transl)].
Djelali D
Ther Umsch; 1973 Aug; 30(8):611-7. PubMed ID: 4751584
[No Abstract] [Full Text] [Related]
28. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
Gulyas M; Fillinger J; Kaposi AD; Molnar M
J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
[TBL] [Abstract][Full Text] [Related]
29. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis.
Esteban JM; Yokota S; Husain S; Battifora H
Am J Clin Pathol; 1990 Dec; 94(6):698-705. PubMed ID: 1700877
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic efficiency of carcinoembryonic antigen and CA125 in the cytological evaluation of effusions.
Pinto MM; Bernstein LH; Rudolph RA; Brogan DA; Rosman M
Arch Pathol Lab Med; 1992 Jun; 116(6):626-31. PubMed ID: 1616424
[TBL] [Abstract][Full Text] [Related]
32. Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions.
To A; Dearnaley DP; Ormerod MG; Canti G; Coleman DV
Am J Clin Pathol; 1982 Aug; 78(2):214-9. PubMed ID: 6179426
[TBL] [Abstract][Full Text] [Related]
33. [Use of immunohistochemistry in clinical cytology].
Weintraub D; Weintraub J; Vassilakos P
Ann Pathol; 1987; 7(1):25-30. PubMed ID: 3304314
[TBL] [Abstract][Full Text] [Related]
34. Immunocytochemical characterization of lymphocytes in benign and malignant lymphocyte-rich serous effusions.
Spieler P; Kradolfer D; Schmid U
Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):211-21. PubMed ID: 3087054
[TBL] [Abstract][Full Text] [Related]
35. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions.
Meyers FJ; Lewis JP; Marianos S
Cancer; 1986 Oct; 58(7):1479-83. PubMed ID: 3742465
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of clot examination for malignant cells in serous effusions.
Jalal R; Aftab K; Hasan SH; Pervez S
Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
38. [Cytological exmaination of effusions as a diagnostic contribution for the internist].
Streit W; Bosselmann H
Med Welt; 1975 Aug; 26(33-34):1443-4. PubMed ID: 1177710
[No Abstract] [Full Text] [Related]
39. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and specificity of cytodiagnosis of body fluids in a laboratory of urgencies.
Rocher AE; Guerra F; Rofrano J; Angeleri A; Canessa OE; Mendeluk GR; Palaoro LA
Biotech Histochem; 2011 Oct; 86(5):326-32. PubMed ID: 20961211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
